Vanda Pharma (VNDA)
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs world...
- Open
- 5.170
- High
- 5.170
- Low
- 4.955
- Prev. Close
- 5.150
- Volume
- 758.87K
- Turnover
- 3.79M
- Avg Price
- 5.000
- Bid/Ask Ratio
- --
- Amplitude
- 4.17%
- 52wk High
- 9.940
- Volume Ratio
- 0.93
- Turnover Ratio
- 1.59%
Vanda Pharma Analyst Rating
View moreForecast & Rating
Aug 10, 2026Price forecast
$12.19144.24%
Forecast & RatingBuy
4analysts
- Strong buy75.00%
- Buy0.00%
- Hold25.00%
- Sell0.00%
- Strong sell0.00%
News
- Quartr · 16 hours ago
VNDA: BYSANTI and NEREUS launches, plus pivotal readouts, set up major growth opportunities ahead
- StockTitan · Sep 2 at 12:51 PM
Vanda Pharmaceuticals Announces Participation at September 2026 Investor Conferences | VNDA Stock News
- Unusual Whales · Sep 1 at 08:16 PM
Anaptys Announces Participation at the H.C. Wainwright 28th Annual Global Investment Conference
- PUBT · Aug 24 at 11:02 AM
Vanda says EU grants orphan drug status to imsidolimab for generalized pustular psoriasis
